Cargando…

A Role for Lipid Mediators in Acute Myeloid Leukemia

In spite of therapeutic improvements in the treatment of different hematologic malignancies, the prognosis of acute myeloid leukemia (AML) treated solely with conventional induction and consolidation chemotherapy remains poor, especially in association with high risk chromosomal or molecular aberrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loew, Andreas, Köhnke, Thomas, Rehbeil, Emma, Pietzner, Anne, Weylandt, Karsten-H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567850/ https://www.ncbi.nlm.nih.gov/pubmed/31100828 http://dx.doi.org/10.3390/ijms20102425

Ejemplares similares

Recent developments in immunotherapy of acute myeloid leukemia
por: Lichtenegger, Felix S., et al.
Publicado: (2017)

Acetylsalicylic Acid Reduces the Severity of Dextran Sodium Sulfate-Induced Colitis and Increases the Formation of Anti-Inflammatory Lipid Mediators
por: Köhnke, Thomas, et al.
Publicado: (2013)

Experimental Evidence of ω-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases
por: Calviello, Gabriella, et al.
Publicado: (2013)

Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
por: Nuno, Kevin A., et al.
Publicado: (2023)

Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022)

Effects of Moringa oleifera Seed Oil on Cultured Human Sebocytes In Vitro and Comparison with Other Oil Types
por: Zouboulis, Christos C., et al.
Publicado: (2023)

Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia
por: Xiao, Yanan, et al.
Publicado: (2023)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Role of autophagy in acute myeloid leukemia therapy
por: Zhang, Su-Ping, et al.
Publicado: (2013)

The dual role of autophagy in acute myeloid leukemia
por: Seo, Wonhyoung, et al.
Publicado: (2022)

The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
por: Hao, Fang, et al.
Publicado: (2021)

Role of Biomarkers in the Management of Acute Myeloid Leukemia
por: Small, Sara, et al.
Publicado: (2022)

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
por: Rothenberg-Thurley, Maja, et al.
Publicado: (2018)

The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)

The role of microRNAs in acute myeloid leukemia
por: Hyde, R Katherine, et al.
Publicado: (2010)

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2019)

Role of CXCR4 in the Pathogenesis of Acute Myeloid Leukemia
por: Peled, Amnon, et al.
Publicado: (2013)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

Unraveling the Role of Innate Lymphoid Cells in Acute Myeloid Leukemia
por: Lordo, Matthew R., et al.
Publicado: (2021)

Present and Future Role of Immune Targets in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2022)

Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia
por: Swaminathan, Mahesh, et al.
Publicado: (2023)

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia
por: Guinn, Barbara-ann, et al.
Publicado: (2007)

Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
por: Leineweber, Can G., et al.
Publicado: (2023)

Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis
por: Weylandt, Karsten-H., et al.
Publicado: (2019)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Acute Myeloid Leukemia in the Elderly Patient: New Strategies
por: Thomas, Xavier
Publicado: (2015)

Acute Myeloid Leukemia: Aging and Epigenetics
por: Zjablovskaja, Polina, et al.
Publicado: (2019)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

miRNAs in acute myeloid leukemia
por: Liao, Qiong, et al.
Publicado: (2016)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Therapies for acute myeloid leukemia: vosaroxin
por: Sayar, Hamid, et al.
Publicado: (2017)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Chromosomal Instability in Acute Myeloid Leukemia
por: de Oliveira Lisboa, Mateus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ck313pmsti4db2hd1nmph57c67